Join to view full profile
9500 Euclid AveGlickman TowerCleveland, OH 44195
Dr. Almaani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Salem Almaani is a Staff nephrologist at the Department of Kidney Medicine, Cleveland Clinic, Ohio. He serves as the director of the Cleveland Clinic Glomerulonephritis Center
Education & Training
University of TorontoPost-doc fellowship, Glomerulonephritis, 2016 - 2017
Ohio State University Wexner Medical CenterPost-Doctoral Fellowship, 2015 - 2016- Ohio State UniversityMS, Medical Science, 2015 - 2016
- Ohio State University HospitalFellowship, Nephrology, 2013 - 2015
OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 2010 - 2013
Certifications & Licensure
OH State Medical License 2010 - 2027
American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Improving the histologic classification of advanced diabetic nephropathy based on the Transformative Research in Diabetic Nephropathy (TRIDENT) findings.Samer Mohandes, Cynthia C Nast, Amy Mottl, Julia Scialla, Salem Almaani
Kidney International. 2026-08-26 - Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort.Samer Mohandes, Mohammad Fakhreddine, Henry Sheng, Mohammed Al Dulaimee, Amy Mottl
Clinical Journal of the American Society of Nephrology. 2026-08-01 - A Combined Transcriptomics and Proteomics Approach to Identify Immune Signatures in ANCA-Associated Glomerulonephritis.Ivana Stojkic, John P Shapiro, Arnon Arazi, Huijuan Song, Pearlly Yan
ACR Open Rheumatology. 2026-07-01
Abstracts/Posters
- AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation OutcomesSalem Almaani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL AmyloidosisSalem Almaani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: